TRVI · Trevi Therapeutics, Inc.
$18.46
+0.31 (+1.71%)
At close · Aug 14
Market Cap
$2.63B
Shares
142.48M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2023-06 | 2025-11 | $200,000,000 | — | — | 10-Q , filed 2026-08-06 |
Key facts
CIK
1563880
CUSIP
89532M101
13F (30d)
213 filings
211 filers
Visit website
Investor relations